Endometriosis drug Visanne added to PBS Doctors have described dienogest as ‘miraculous’, with its listing expected to positively impact up to 500,000 patients.
RACGP calls for GP permission to provide diabetes technology access As part of a consultation process for subsidised access to continuous glucose monitoring, the college says GPs are ‘essential’ to supporting equitable access.
New Chair for RACGP Funding and Health System Reform Associate Professor Rashmi Sharma is stepping up at a ‘pivotal moment for the profession’ and has shared her goals for the future.
‘Unprecedented’ demand on PBAC forces extra meeting Its capacity has been exceeded by a ‘huge pipeline of new medicines’, after companies put forward a record number of submissions.
Medicare watchdog repayments soar by $10m The PSR recouped $32 million from negotiated agreements and determinations last year, often through doctors’ ‘lack of clinical input and poor record keeping’.
Final Review of General Practice Incentives report revealed It recommends a suite of changes which, if accepted, would see GPs’ incentives undergo a major shakeup, including a new payment architecture and a shift in the foundation of general practice.
Action taken amid continuing PrEP shortage As supply of the HIV prevention medication continues to be disrupted, the Federal Government has listed a US brand on the PBS to shore up access.
City PBS prescription rates double those in very remote areas One GP says there simply are not enough remote doctors, as new data finds the people living there are accessing medication at a much lower rate.
Admin burden top reason GPs plan to leave practice: RACGP In a ‘wakeup call’ for governments, the new Health of the Nation report found 70% of GPs are concerned about their admin workload.
PBS additions for cancer and epilepsy Tens of thousands of patients each year are set to benefit from several first-time additions, including Zyamis and Tecentriq SC.